Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Atea Pharmaceuticals, Inc. | 127,665 | reported | 31 Jan 2026 | tx 19+1,463,400−193,949 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 Jan 2026 | EXERCISE | Atea Pharmaceuticals, Inc. | 58,050 | — | |
| 31 Jan 2026 | TAX_WITHHOLDING | Atea Pharmaceuticals, Inc. | 14,136 | 4.24 USD | |
| 31 Jan 2026 | EXERCISE | Atea Pharmaceuticals, Inc. | 11,250 | 0.00 USD | deriv |
| 31 Jan 2026 | EXERCISE | Atea Pharmaceuticals, Inc. | 46,800 | 0.00 USD | deriv |
| 31 Jan 2026 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 177,000 | 0.00 USD | deriv |
| 31 Jan 2025 | EXERCISE | Atea Pharmaceuticals, Inc. | 46,800 | — | |
| 31 Jan 2025 | TAX_WITHHOLDING | Atea Pharmaceuticals, Inc. | 14,134 | 3.06 USD | |
| 31 Jan 2025 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 11,250 | — | |
| 31 Jan 2025 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 11,250 | 0.00 USD | deriv |
| 31 Jan 2025 | EXERCISE | Atea Pharmaceuticals, Inc. | 46,800 | 0.00 USD | deriv |
| 31 Jan 2025 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 200,000 | 0.00 USD | deriv |
| 01 Feb 2024 | SALE | Atea Pharmaceuticals, Inc. | 14,029 | 3.84 USD | |
| 31 Jan 2024 | EXERCISE | Atea Pharmaceuticals, Inc. | 46,800 | — | |
| 31 Jan 2024 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 225,200 | 0.00 USD | deriv |
| 31 Jan 2024 | EXERCISE | Atea Pharmaceuticals, Inc. | 46,800 | 0.00 USD | deriv |
| 31 Jan 2023 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 140,400 | 0.00 USD | deriv |
| 31 Jan 2023 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 196,600 | 0.00 USD | deriv |
| 31 Jan 2022 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 190,000 | 0.00 USD | deriv |
| 29 Jan 2021 | GRANT_AWARD | Atea Pharmaceuticals, Inc. | 160,050 | 0.00 USD | deriv |